The effect of fibrin extracellular matrix properties for the in vitro angiogenesis assay by Ishak, Siti Amirah
  
 
 
THE EFFECT OF FIBRIN EXTRACELLULAR MATRIX PROPERTIES FOR THE 
IN VITRO ANGIOGENESIS ASSAY 
 
 
 
 
 
 
 
 
 
 
 
SITI AMIRAH BINTI ISHAK 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI TEKNOLOGI MALAYSIA 
  
 
 
THE EFFECT OF FIBRIN EXTRACELLULAR MATRIX PROPERTIES FOR THE 
IN VITRO ANGIOGENESIS ASSAY 
 
 
 
 
SITI AMIRAH BINTI ISHAK 
 
 
 
 
This thesis is submitted in fulfillment of the 
 requirements for the award of  
degree of Master of Engineering (Biomedical) 
 
 
 
 
Faculty of Biosciences and Medical Engineering 
Universiti Teknologi Malaysia 
 
 
 
 
 
JANUARY 2015 
iii 
 
 
 
 
 
 
 
 
Special dedication and thanks to: 
 
 
My ever present and inspiring family; 
My father, Ishak Bin ABD Wahab 
My mother, Che Aishah Bte Che Wang 
My brother, Ahmad Syafiq Akmal Bin Ishak 
My sister, Siti Khalida Binti Ishak 
My sister, Siti Maisarah Binti Ishak 
My youngest brother, Ahmad Luqman Hakim Bin Ishak 
My youngest sister, Siti Nurfathihah Binti Ishak 
 
My loving and supporting friend; 
Nur Najiha Binti Saarani 
Nik NurZuliyana Binti Rajdi 
Nur Syazana Binti Rashidi 
Noor Jasmawati Binti Mat Noor 
 
 
iv 
 
ACKNOWLEDGEMENT 
 
 
 
 
First and foremost, I would like to give praise and grateful to ALLAH, the 
Almighty, for giving me patience and hardiness in completing my research. With Allah 
blessings and guidance especially on the most difficult time, I was able to complete my 
Master project. 
 
Next, I would like to express my sincere gratitude to my supervisor, Prof. Dr. 
Ir.Mohammed Rafiq Bin Dato’ Abdul Kadir and my co-supervisor Dr. Irza Sukmana for 
being an outstanding advisor which made them a backbone of this research as well as to 
this thesis. Their constant support, advice, supervision and guidance from the very early 
stage of this research have made this work successful. Without their help and guidance, 
the success of this project would not have been possible. They have been extremely 
helpful and inspiring as well. 
 
My thanks also go out to all my friends for being there for me, helping me as 
well as guiding me in conducting the research. Their presence gave me a lot of 
encouragement to overcome the problems I faced during the research with sheer 
determination. I would also like to take this opportunity to acknowledge Universiti 
Teknologi Malaysia (UTM) Skudai, faculty of Biosciences & Medical Engineering and 
Ministry of Higher Education (MOHE) for my master scholarship. Last but not least, to 
my parents and siblings I dedicate this dissertation to you. Your heartfelt support and 
unconditional love give me strength and comfort. Words cannot express how grateful I 
am for all the years of character building and encouragement I receive. 
v 
 
ABSTRACT 
 
 
 
 
Angiogenesis, the formation of new vascular network from the pre-existing vasculature, 
has been studied in the connection to the normal developmental process as well as 
numerous diseases. In tissue engineering research, angiogenesis is also essential to 
promote micro-vascular network inside engineered tissue constructs, mimicking a 
functional blood vessel in vivo. Besides, the formation of new blood vessels depends 
strongly on the extracellular matrix such as fibrin gel. In this study, we investigate the 
effect of four different ratio of fibrinogen (mg/mL) to thrombin (Units/mL) composition 
(i.e., 2:1, 1:2, 1:8, 8:1), on the physical properties of fibrin gel and the role of fibrin gel 
for angiogenesis assay with HSF. Some properties of fibrin gel such as clotting time, 
water uptake property, turbidity and microstructure observation was studied. Higher 
concentration of thrombin (i.e., 8:1 mg/U) will yields a shorter clotting time of the fibrin 
gel when compared to the lower concentration of thrombin (i.e 1:8 mg/U). Fibrin gel 
with higher thrombin and lower fibrinogen concentration (i.e., 1:8 mg/U) are not stable 
enough to withstand the amount of PBS subjected to it hence it cannot absorb water well 
compared to other fibrin gel concentration. Meanwhile, at higher concentration of 
thrombin, the turbidity study shows the lowest absorbance compared to other samples. 
Different ratio of fibrinogen to thrombin may affect the microstructure of the fibrin gel 
produced. Microstructure observation proved that fibrin gel produced in this study 
shows the fibrous structure. The last part of this experiment also proved that fibrin gel 
with ratio of 2:1 mg/U of fibrinogen to thrombin reveal the best tube-like structure 
which has the highest number of nucleus as well as highest number of tube-like structure 
formed after 48 hours. 
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ABSTRAK 
 
 
 
 
Angiogenesis, pembentukan rangkaian vaskular baru dari vaskulatur yang sedia ada, 
ianya telah dikaji berkaitan dengan proses perkembangan yang normal dan juga banyak 
penyakit. Dalam penyelidikan kejuruteraan tisu , angiogenesis juga penting untuk 
menggalakkan rangkaian mikro vaskular dalam membina kejuruteraan tisu. Selain itu, ia 
juga mampu menyerupai fungsi saluran darah in vivo. Tambahan itu pula, pembentukan 
saluran darah yang baru bergantung sepenuhnya pada matriks luar sel seperti gel fibrin. 
Dalam kajian ini, kami turut mengkaji kesan empat nisbah fibrinogen (mg/mL) dan 
thrombin (Unit/mL) yang berbeza komposisi terhadap sifat-sifat fizikal fibrin gel dan 
juga peranannya kepada assay angiogenesis dengan menggunakan HSF. Masa 
pembekuan, penyerapan air, kekeruhan dan pemerhatian mikrostruktur telah dikaji. Gel 
fibrin pada kepekatan thrombin yang lebih tinggi (i.e., 8:1 mg/U) akan menghasilkan 
masa pembekuan yang lebih pendek jika dibandingkan dengan kepekatan thrombin yang 
rendah (i.e 1:8 mg/U). Selain itu, gel fibrin dengan kepekatan thrombin yang tinggi dan 
fibrinogen yang rendah (i.e., 1:8 mg/U) tidak cukup stabil untuk menahan PBS yang 
menyebabkan penyerapan yang tidak baik berbanding dengan gel fibrin lain. Sementara 
itu, thrombin pada kepekatan yang lebih tinggi menunjukkan tahap kekeruhan yang 
paling rendah berbanding dengan sample yang lain. Perbezaan nisbah fibrinogen dan 
thrombin juga memberi kesan kepada struktur mikro gel fibrin . Pemerhatian 
mikrostruktur juga membuktikan bahawa gel fibrin menunjukkan struktur yang 
berserabut. Bahagian terakhir eksperimen ini juga membuktikan bahawa gel fibrin pada 
nisbah 2:1 mg / U menunjukkan struktur tiub yang paling sempurna kerana 
menunjukkan jumlah nukleus dan struktur tiub yang tertinggi selepas 48 jam. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Research Background 
 
 
Tissue engineering research plays an important role to support clinicians and 
medical experts in increasing human life quality through the development of engineered 
tissues and biological substitutes for a desired human organ. It also gives promises in 
regenerative medicine through the treatment of variety diseases by providing some 
biomaterials for organ transplant. To this context, tissue engineering aims to repair, 
replace or regenerate damaged tissues or organ in the body that was incapable to 
regenerate. Although there has been tremendous success in tissue engineering to support 
treatment of broad variety of diseases, some challenges still remain. One of the 
challenges is to develop a vascularized engineering tissue construct that facilitate blood 
microvessel network within the thick scaffold. Vascularized tissue is an essential factor 
for cell survival as well as tissue growth and integration (Anderson et al., 2011). 
Another challenge is also to generate an in vitro angiogenesis assays to study the step-
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by-step development of microvasculature network inside engineering tissue construct 
(Sukmana, 2011). 
 
 
Although massive progress has been made, some major problems on mass 
production of human tissue are still remaining. The lack of a sufficient supply of 
nutrients and oxygen to the implanted tissue as well as waste removal are the limiting 
factors for the successful implantation of tissue engineered constructs and leads in many 
cases to the failure of the implant (Atala, 2004). Pre-vascularization of the tissue-
scaffolds construct is the most favorable trend to deal with that problem. The idea of 
pre-vascularization is mainly incorporation of endothelial cells or vascular-like 
structures in the tissue-engineered constructs and then to implant the material at the 
desired site. This approach could favor a link between the existing vasculature from the 
host and the endothelialized tissue construct and furthermore accelerate the formation of 
functional micro-vessels in the inner parts of the implant (Godbey and Atala, 2002). 
 
 
Angiogenesis is a key mechanism on the development of new blood vessels. It 
was firstly pioneered by Folkman and his colleague over the last two decades when 
demonstrated a new capillary blood vessels in tumor progression (Folkman, 1980).  
Disorder angiogenesis also founded in more than 70 pathogenic problems as reported by 
Carmeliet (Carmeliet, 2000). The development of new blood vessels is also very 
important in the process of organ growth and during wound healing (Carmeliet, 2000). 
Some researchers have been developed a system to fabricate capillary-like network and 
angiogenesis in a 3-dimensional environment of bio-gel assays (Sanders 2002). 
Although there are some aspects of angiogenesis modulations can be described, but the 
formation of micro-vessels and lumen are often intracellular rather than surrounded and 
multi-cellular (Nakatsu et al., 2003). 
 
 
 This study aims to explore the potential use of fibrin gel as extracellular matrix 
for the angiogenesis assay. Angiogenesis is a complex process by which blood micro 
vessels developed from the pre-existing vascularate (Linnes et al., 2007). In this 
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research, the effect of different ratio of fibrinogen to thrombin for fibrin gel has been 
evaluated with respect to the tube-like structure development of human skin fibroblast 
(HSF). Fibrinogen is one of the most important natural proteins in the body that support 
the vascular growth during development. 
 
 
 
 
1.2 Problem Statement 
 
 
 Tissue engineering research involves on the development of specific tissues in 
order to replace the damage tissue inside the body when the body is incapable of 
regenerating it back (Lanza et al., 2007). However, a vascular supply is typically 
required in order to support the growth and survival of growing cell within the implant 
(Anderson et al., 2011). Therefore, it is highly important to promote angiogenesis in 
tissue engineering so that the new blood vessel growth can support the survival of 
growing tissue. 
 
 
 The use of natural polymer scaffold is one of the possible ways to create a 
vascularized tissue construct within the implant. Natural polymers have been widely 
used in many applications in biomedical as well as tissue engineering compared to 
synthetic polymer. Collagen is one of the popular natural polymers that have been used 
in research that related to the development of angiogenesis. However, there are still 
drawbacks of using collagen as the scaffold because collagen can be very difficult to 
purify while maintaining their architecture (Dubiel et al., 2011). During the process of 
purification, small amounts of impurities may cause unexpected cell response that will 
influence the result in culture system. Besides collagen, fibrin gel is another natural 
polymer that seems to have potential in supporting the development of angiogenesis 
(Sukmana, 2012). In this research, instead of using collagen, the biophysical properties 
of fibrin gel were investigated in order to observe their effect toward the development of 
angiogenesis study. 
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 Angiogenesis is one of the important process and fundamental to many 
physiological and pathological diseases especially in cardiovascular diseases, chronic 
wound healing and also to overcome problem related to tissue engineering. All of these 
diseases are characterized by dependence on a new blood vessel formation for adequate 
supply of oxygen, nutrients as well as removal of waste (Griffioen and Molema, 2000). 
Although there have been some aspects on the development of angiogenesis research, 
however, the step-by-step of tube-like structure formation is still lacking such as the 
effect of fibrinogen to thrombin concentration on the tube-like structure development.  
 
 
 
 
1.3 Research Objective 
 
 
The objectives of this study were:  
 
 
a) To modulate the effect biophysical properties of fibrin gel for three 
dimensional angiogenesis assays. 
 
b) To study the role of fibrin gel on angiogenesis development of Human Skin 
Fibroblast (HSF)  
 
 
 
 
1.4 Scope of Research 
 
 
The study is conducted to produce fibrin gel for the in vitro angiogenesis assays 
of HSF by modulation of fibrinogen and thrombin concentrations. Different ratio of 
fibrinogen as well as thrombin will be studied in order to investigate their effect toward 
the biophysical properties of fibrin gel produced. The variation of these properties will 
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be then manipulated to be used for in vitro angiogenesis with HSF (human skin 
fibroblast). 
 
 
 
 
1.5 Significance of Research 
 
 
 Fibrin gel has broad applications in various biomedical engineering fields, 
including haemostate glue and wound repair, drug delivery, cell delivery, cell 
differentiation and also tissue engineering. In addition, fibrin gel continue revealing its 
fascinating features of self-assembly and soft elasticity by which it can resist stretching 
to more than five times its resting length without breakage. Although fibrin gel provide 
many potential in clinical application especially wound healing, but the healing of any 
skin wound other than the most superficial cannot occur without angiogenesis. This is 
because, not only the damage vasculature need to be repaired but in order to increased 
local cell activity, increased supply of nutrients from the bloodstream is typically 
required in the process of wound healing. This is why, the biophysical properties of 
fibrin gel is very important as its function is normally used to support the angiogenesis 
process. Therefore, this study will help to expand the research and development in 
regenerative medicine and tissue engineering. 
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